- Home
- DIBS vs NBTX Comparison
DIBS vs NBTX Comparison
Compare DIBS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- NBTX
- Stock Information
- Founded
- DIBS 2000
- NBTX 2003
- Country
- DIBS United States
- NBTX France
- Employees
- DIBS N/A
- NBTX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- NBTX Health Care
- Exchange
- DIBS Nasdaq
- NBTX Nasdaq
- Market Cap
- DIBS 175.8M
- NBTX 201.9M
- IPO Year
- DIBS 2021
- NBTX 2020
- Fundamental
- Price
- DIBS $3.63
- NBTX $3.26
- Analyst Decision
- DIBS Buy
- NBTX Strong Buy
- Analyst Count
- DIBS 2
- NBTX 1
- Target Price
- DIBS $8.00
- NBTX $12.00
- AVG Volume (30 Days)
- DIBS 207.6K
- NBTX 64.6K
- Earning Date
- DIBS 11-08-2024
- NBTX 12-31-2024
- Dividend Yield
- DIBS N/A
- NBTX N/A
- EPS Growth
- DIBS N/A
- NBTX N/A
- EPS
- DIBS N/A
- NBTX N/A
- Revenue
- DIBS $86,409,000.00
- NBTX $45,220,186.00
- Revenue This Year
- DIBS $5.17
- NBTX N/A
- Revenue Next Year
- DIBS $7.90
- NBTX N/A
- P/E Ratio
- DIBS N/A
- NBTX N/A
- Revenue Growth
- DIBS N/A
- NBTX 526.17
- 52 Week Low
- DIBS $3.37
- NBTX $2.76
- 52 Week High
- DIBS $6.30
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- DIBS 38.06
- NBTX 42.55
- Support Level
- DIBS $3.42
- NBTX $3.18
- Resistance Level
- DIBS $3.79
- NBTX $3.69
- Average True Range (ATR)
- DIBS 0.16
- NBTX 0.27
- MACD
- DIBS -0.01
- NBTX 0.07
- Stochastic Oscillator
- DIBS 26.79
- NBTX 56.45
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company's single reportable and operating segment contains two reporting units; 1stDibs, which consists of the company's online marketplace that enables commerce between sellers and buyers; and Design Manager, which is the company's separate online platform that is used to sell a software solution to interior designers. It generates revenue primarily from fees from seller marketplace services as well as other services, including advertisements and software services.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.